54.35 USD
↗ 5.81 (11.97%)AT CLOSE (11:59 AM EDT)
Moderna, Inc. Common Stock
MRNANASDAQ • USD
54.36
↗ 0.01 (0.02%)
POST MARKET (AS OF 07:59 PM EDT)
Post Market
AS OF 07:59 PM EDT
54.36
↗ 0.01 (0.02%)
Market: CLOSED
Open?$49.00
High?$57.78
Low?$48.98
Prev. Close?$48.54
Volume?20.9M
Avg. Volume?6.4M
VWAP?$54.45
Rel. Volume?3.25x
Bid / Ask
Bid?$50.77 × 100
Ask?$56.39 × 100
Spread?$5.62
Midpoint?$53.58
Valuation & Ratios
Market Cap?21.6B
Shares Out?396.8M
Float?346.8M
Float %?88.8%
P/E Ratio?N/A
P/B Ratio?2.91
EPS?-$8.05
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 35 mRNA development candidates in clinical studies as of August 2025. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
Themes
Employees
4.7K
Market Cap
21.6B
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
Listed
2018-12-07
Address
325 BINNEY STREET
CAMBRIDGE, MA 02142
Phone: (617) 714-6500
CAMBRIDGE, MA 02142
Phone: (617) 714-6500
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?2.41Strong
Quick Ratio?2.35Strong
Cash Ratio?0.80Adequate
Debt/Equity?0.08Low
ValuationFAIRLY VALUED
Score67/100
P/E?N/A▾
P/B?2.91CHEAP▾
P/S?9.69HIGH▾
P/FCF?N/A▾
EV/EBITDA?-6.4CHEAP▾
EV/Sales?9.11HIGH▾
Returns & Efficiency
ROE?-43.1%WEAK▾
ROA?-27.8%WEAK▾
Cash Flow & Enterprise
FCF?$-1603000000
Enterprise Value?$20.3B
Fundamentals ratios updated end of day